A U.S. Food and Drug Administration advisory panel narrowly voted to recommend that regulators approve a controversial heart device made by Boston Scientific Corp., despite their concerns that the device isnâ€™t as effective as standard drug therapy in preventing the most common type of stroke. . Boston Scientific is seeking FDA approval to sell its Watchman device as an alternative to standard drug therapy for patients suffering from atrial fibrillation, an abnormal heartbeat condition known to cause stroke. It affects some...
  